Table 2.
Deterministic results for ONDRISeq versus out-of-country genetic testing
Total cost (CAD) per patient | Total QALYs per patient | Incremental cost (ONDRISeq—OOC) per patient | Incremental QALYs (ONDRISeq—OOC) per patient | Incremental cost- effectiveness ratio per patient | Incremental net monetary benefit (at $50,000 per QALY; CAD) per patient | |
---|---|---|---|---|---|---|
OOC | $324,058 | 10.801 | ||||
ONDRISeq | $324,005 | 10.802 | − $53.56 | 0.0014 | Dominates OOC | $127.49 |